Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Epoxyalkanoyls as novel ACE inhibitors

  • 46 Accesses

  • 1 Citations


The epoxyalkanoyl derivatives were designed and synthesized as ACE inhibitors. Coupling of unsaturated carboxylic acids with amino acids and following epoxidation with dimethyldioxirane gave the epoxyalkanoyls with high yield. The inhibitory activity of synthesized compounds on angiotensin converting enzyme was IC50 values of 0.06≈5.5 μM.

This is a preview of subscription content, log in to check access.

References Cited

  1. Beckwith, A. C. J., O'Shea, D. M. and Westwood, S. W., Rearrangement of suitably constituted aryl, alkyl or vinyl radicals by acyl or cyano group migration.J. Am. Chem. Soc. 110, 2565–2575 (1988).

  2. Cheung, H. S., Wang, F. L., Ondetti, M. A., Sabo, E. F., and Cushman, D. W.; Binding of peptide substrates and inhibitors of angiotensin converting enzyme.J. Biol. Chem. 255, 401–407 (1980).

  3. Corey, P. F. and Ward, F. E., Buffered potassium peroxymonosulfate-acetone epoxidation of a,b-unsaturated acids.J. Org. Chem. 51, 1925–1928 (1986).

  4. Cushman D. W., Cheung H. S., Sabo E. F.; Design of potent competitive inhibitors of angiotensin converting enzyme carboxyalkanoyl and mercaptoalkanoyl amino acids.Biochemistry. 16, 5484–5491 (1977).

  5. Cushman, D. W. and Ondetti, M. A.; Inhibitors of angiotensin-converting enzyme for treatment of hypertension.Biochem. Pharmacol. 29, 1871–1877 (1980).

  6. Kim, D. H., Guinosso, C. J., Buzby, Jr. J. C., Herbst, D. R., McCaully, R. J., Wicks, T. M., and Wendt, R. L.; (Mercaptopropanoyl)indoline carboxylic acids and related compounds as potent angiotensin converting enzyme inhibitors and antihypertensive agents,J. Med. Chem. 26, 394–403 (1983).

  7. Kim, D. H. and Kim, K. B.; Design of a novel type of zinc-containing protease inhibitor.J. Am. Chem. Soc. 113, 3200–3202 (1991).

  8. Kostis, J. B., Raia Jr., J. J., Defielice, E. A., Baronee, J. A. and Deeter, R. G., Comparative clinical pharmacology of ACE inhibitors inAngiotensin converting enzyme inhibitors Kostis, J. B. and Defelice, E. A. eds., Alan R. Liss, Inc New York, 1987

  9. Ondetti, M. A. and Cushman, D. W. US patent 41046889, 1977

  10. Ondetti, M. A., Rubin, B. and Cushman, D. W.; Design of specific inhibitors of angiotensin-converting enzyme; new clss of orally active antihypertensive agents.Science, 196, 441–444 (1977).

  11. Pascard, C., Guilhem, J. and Vincent, M.; Configuration and preferential solid-state conformations of perindoprilat (S-9780). Comparison with the crystal structures of other ACE inhibitors and conclusions related to structure-activity relationshps.J. Med. Chem. 34, 663–660 (1991).

  12. Patchett, A. A., Enalapril and lisinopril in Chronicles of Drug Discovery D. Lednicer ed.American Chemical Society 125–162 (1993).

  13. Sum, P.-E. and Weiler, L.; Synthesis of exo- and endobrevicomin and frontalin.Can. J. Chem. 57, 1475–1480 (1979).

  14. Weiler, L.; Alkylation of the dianion of β-kato esters.J. Am. Chem. Soc. 92, 6702–6702 (1970).

  15. Yoo, S. E., Kim, H. and Jeong, N.; A high efficient epoxidation of vinylteterazoles and its application,Korean J. Med. Chem. 1, 65–68 (1991).

Download references

Author information

Correspondence to Hea-Young P. Choo.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Choo, H.P., Yoon, H., Park, H. et al. Epoxyalkanoyls as novel ACE inhibitors. Arch. Pharm. Res. 21, 168–173 (1998). https://doi.org/10.1007/BF02974023

Download citation

Key words

  • Epoxides
  • Angiotensin converting enzyme inhibitor
  • Irreversible inhibition